Reactivation of HBV can be prevented, treated during immunosuppressive drug therapy

Long-term immunosuppressive therapy can cause the hepatitis B virus to become active, even in patients who are not aware that they are infected with the virus. A new guideline from the American Gastroenterological Association provides guidance to physicians and patients who use immunosuppressive agents for the treatment of a variety of disorders, including gastrointestinal, dermatologic, neurologic and rheumatologic, among others. —> Read More Here


Leave a Reply

Your email address will not be published. Required fields are marked *